Join Growin Stock Community!

Phibro animal health corporationPAHC.US Overview

US StockHealthcare
(No presentation for PAHC)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

PAHC AI Insights

PAHC Overall Performance

PAHC AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

PAHC Recent Performance

-1.56%

Phibro animal health corporation

0.05%

Avg of Sector

-0.31%

S&P500

PAHC PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

PAHC Key Information

PAHC Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

PAHC Profile

Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It operates in the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 2014 and is headquartered in Teaneck, New Jersey.

Price of PAHC

PAHC FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

PAHC Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
2.27
PE Ratio (TTM)
24.15
Forward PE
45.83
PS Ratio (TTM)
1.51
PB Ratio
6.68
Price-to-FCF
46.75
METRIC
VALUE
vs. INDUSTRY
Gross Margin
31.89%
Net Margin
6.29%
Revenue Growth (YoY)
32.39%
Profit Growth (YoY)
32.63%
3-Year Revenue Growth
15.19%
3-Year Profit Growth
19.68%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
2.27
PE Ratio (TTM)
24.15
Forward PE
45.83
PS Ratio (TTM)
1.51
PB Ratio
6.68
Price-to-FCF
46.75
Gross Margin
31.89%
Net Margin
6.29%
Revenue Growth (YoY)
32.39%
Profit Growth (YoY)
32.63%
3-Year Revenue Growth
15.19%
3-Year Profit Growth
19.68%

  • When is PAHC's latest earnings report released?

    The most recent financial report for Phibro animal health corporation (PAHC) covers the period of 2026Q2 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating PAHC's short-term business performance and financial health. For the latest updates on PAHC's earnings releases, visit this page regularly.

  • What is the operating profit of PAHC?

    According to the latest financial report, Phibro animal health corporation (PAHC) reported an Operating Profit of 50.33M with an Operating Margin of 13.46% this period, representing a growth of 97.1% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is PAHC's revenue growth?

    In the latest financial report, Phibro animal health corporation (PAHC) announced revenue of 373.91M, with a Year-Over-Year growth rate of 20.9%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does PAHC have?

    As of the end of the reporting period, Phibro animal health corporation (PAHC) had total debt of 731.24M, with a debt ratio of 0.52. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does PAHC have?

    At the end of the period, Phibro animal health corporation (PAHC) held Total Cash and Cash Equivalents of 55.49M, accounting for 0.04 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does PAHC go with three margins increasing?

    In the latest report, Phibro animal health corporation (PAHC) achieved the “three margins increasing” benchmark, with a gross margin of 35.5%%, operating margin of 13.46%%, and net margin of 7.3%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess PAHC's profit trajectory and future growth potential.

  • Is PAHC's EPS continuing to grow?

    According to the past four quarterly reports, Phibro animal health corporation (PAHC)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 0.68. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of PAHC?

    Phibro animal health corporation (PAHC)'s Free Cash Flow (FCF) for the period is 8.26M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 273.94% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of PAHC?

    The latest valuation data shows Phibro animal health corporation (PAHC) has a Price-To-Earnings (PE) ratio of 18.05 and a Price/Earnings-To-Growth (PEG) ratio of 2.99. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.